Literature DB >> 7461022

The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.

J V Willis, D B Jack, M J Kendall, V A John.   

Abstract

Six healthy subjects took diclofenac as an enteric-coated preparation twice daily for 17 days under the following conditions: (i) fasting, (ii) 15 min before a meal, and (iii) immediately after a meal. Urine specimens were collected on two separate days of each regimen and diclofenac and its total monohydroxylated metabolites measured. Statistical analysis of the excretion of diclofenac and its metabolites showed that, during chronic administration, absorption was not significantly influenced by dosing before or after food. The absorption pattern after both these modes of administration was comparable to that obtained under fasting conditions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461022     DOI: 10.1007/bf00558382

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography.

Authors:  A Schweizer; J V Willis; D B Jack; M J Kendall
Journal:  J Chromatogr       Date:  1980-07-25

2.  Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.

Authors:  C Bogentoft; I Carlsson; G Ekenved; A Magnusson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

3.  Quantitative assay of diclofenac in biological material by gas-liquid chromatography.

Authors:  U P Geiger; P H Degen; A Sioufi
Journal:  J Chromatogr       Date:  1975-09-03

4.  Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile.

Authors:  H Stierlin; J W Faigle
Journal:  Xenobiotica       Date:  1979-10       Impact factor: 1.908

5.  Diclofenac sodium (Voltaren) and indomethacin in the ambulatory treatment of rheumatoid arthritis: a double-blind multicentre study.

Authors:  O Mutru; M Penttilä; J Pesonen; P Salmela; O Suhonen; T Sonck
Journal:  Scand J Rheumatol Suppl       Date:  1978

6.  Report on a long-term tolerability study of up to two years with diclofenac sodium (Voltaren).

Authors:  S N Ciccolunghi; H A Chaudri; B I Schubiger; R Reddrop
Journal:  Scand J Rheumatol Suppl       Date:  1978

7.  The pharmacokinetics of diclofenac sodium following intravenous and oral administration.

Authors:  J V Willis; M J Kendall; R M Flinn; D P Thornhill; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

8.  The influence of food on the absorption of diclofenac after single and multiple oral doses.

Authors:  J V Willis; M J Kendall; D B Jack
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  8 in total
  12 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  The effects of food on drug bioavailability.

Authors:  P A Winstanley; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 3.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 4.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

5.  Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen.

Authors:  I F Trocóniz; S Armenteros; M V Planelles; J Benítez; R Calvo; R Domínguez
Journal:  Clin Pharmacokinet       Date:  2000-06       Impact factor: 6.447

6.  Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen.

Authors:  A Le Liboux; M Teule; A Frydman; B Oosterhuis; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Pharmacokinetics of diclofenac sodium after intramuscular administration in combination with triamcinolone acetate.

Authors:  H Derendorf; G Mullersman; J Barth; A Grüner; H Möllmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease.

Authors:  P R Crook; J V Willis; M J Kendall; D B Jack; P D Fowler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.